IMPACT OF PRETRANSPLANT IVIG ADMINISTRATION ON ANTI-AB0 ANTIBODY LEVELS IN AB0-INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION

Authors :: Rolf Weimer
Andreas Feustel
W. A. Stertmann
S. Wienzek-Lischka
F Renner
Winfried Padberg
Gregor Bein
Source :: Transplantation Journal. 90:937
Publication Year :: 2010
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2010.

Subjects :: Transplantation
business.industry
Immunology
Medicine
Antibody level
business
medicine.disease
Living donor
Administration (government)
Kidney transplantation

Full Text Access

Tools